A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...